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Abstract
The gold standard for aortic endograft infection includes the excision of infected endograft, debridement, and reconstruction. 
However, these methods are not always the best option for patients with poor clinical status. We assessed the suitability of 
alternative methods for managing aortic endograft infection. The patient was a 72-year-old man whose previous abdominal 
surgeries provoked recurrent cholangitis. The patient had also undergone thoracic endovascular aortic repair (TEVAR). One 
month after the TEVAR, he was readmitted with high-grade fever and diagnosed with endograft infection. Due to his frail 
condition, we chose a less invasive and conservative strategy; thoracoscopic drainage with endograft preservation, followed 
by continuous irrigation. He recovered well, and has survived more than 2 years after the drainage procedure. In unstable 
patients or those with severe comorbidities who cannot tolerate endograft excision, thoracoscopic drainage with endograft 
preservation is less invasive, and can be a bridging or temporary solution.
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Introduction
Endograft infection is one of the most serious complica-
tions after thoracic endovascular aortic repair (TEVAR) with 
reported incidence of 0.2–5.0% [1]. Complete excision of 
the infected endograft, aggressive debridement, and aortic 
reconstruction is an optimal but invasive countermeasure 
to infection; it is, therefore, not applicable in all cases, and 
endograft preservation with antibiotics can be considered as 
a bridging therapy until excision of the infected endograft is 
performed in a more stable clinical condition [2]. Regarding 
the approach for drainage, thoracoscopic maneuver is less 
invasive than aortic surgery with thoracotomy in terms of 
giving less pain and greater patient acceptance postopera-
tively [3]. We present a case with endograft infection after 
TEVAR, who was treated with thoracoscopic drainage fol-
lowed by continuous irrigation.
Case report
The patient was a 72-year-old man, whose previous surgical 
history included: intestinal repair for its rupture resulting 
from a traffic accident at 40 years of age, cholecystectomy 
for choledocholithiasis at 62 years, and pancreatoduodenec-
tomy for pancreatic neoplasms when he was 63 years old. 
Although these previous abdominal surgeries had provoked 
recurrent cholangitis, his cholangitis had been treated well 
and under control in those days. We subsequently considered 
the intervention for thoracic aortic aneurysm, and presented 
him with the surgical choices: aortic surgery or thoracic end-
ovascular aortic repair (TEVAR). He chose TEVAR because 
of its less invasiveness, and then we proceeded with TEVAR, 
with right common carotid–left common carotid–left sub-
clavian artery bypass (Fig. 1a). He recovered well and was 
discharged without any complication. One month after the 
TEVAR, he was readmitted with high-grade fever and diag-
nosed with a recurrence of cholangitis. Escherichia coli 
was detected in his blood culture. Computed tomography 
(CT) on admission did not demonstrate endograft infection 
(Fig. 1b). Although the patient was started on cefozopran 
(3.0 g/day), he remained febrile (38.0–38.5 °C); his white 
blood cell (WBC) count was 15,000–20,000/µL and C-reac-
tive protein (CRP) level was 15–20 mg/dL for more than 
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7 days. Repeated CT revealed contrast enhancement around 
the endograft, fluid collection inside the remnant aneurysm 
(Fig. 1c-1) and a fluid cavity (roughly the size of a chicken 
egg) between the aortic arch and pulmonary artery (Fig. 1c-
2). No endoleak was confirmed. We assumed that the patho-
gen of cholangitis spread via blood stream, which resulted 
in endograft infection. Endograft infection might induce 
endoleak, endograft migration or aortic rupture. Although 
his cholangitis might be on active phase, we had priority to 
treat endograft infection initially.
Though the endograft excision with aortic reconstruction 
was optimal, we considered that the patient could not toler-
ate invasive aortic surgery with thoracotomy. His activity 
of daily life (ADL) was maintained at low level; he could 
communicate with others properly and did not have cog-
nitive dysfunction such as dementia. However, he needed 
help for eating, changing clothes, and for the use of toi-
let, in daily life. He could walk a little but basically was 
on wheel chair during daytime. He suffered from severe 
chronic obstructive pulmonary disease, and treated with β2 
stimulator inhalation. Pulmonary functional test revealed 
45% of forced expiratory volume 1 s % (FEV 1.0%) and 
0.9 L of forced expiratory volume 1 s (FEV 1.0). He also 
had septic cholangitis, with relatively high Euroscore II of 
15.6. We also considered replaced-graft reinfection due to 
active and smoldering cholangitis. In addition, because of 
his abdominal surgical history, omental coverage was not an 
option. Therefore, we chose a less invasive and conservative 
strategy; thoracoscopic drainage with endograft preserva-
tion, followed by continuous irrigation.
Using a thoracoscopic surgical system through several 
access ports, we made an incision on the lateral side of the 
distal arch aneurysm (Fig. 2a) and created a 5-cm-length 
fenestration, which extended to the sub-aortic bulging area 
(Fig. 2b). The purulent fluid, which E. coli was cultured on 
later, erupted from the fenestration. We performed irrigation 
with copious saline containing gentamycin, in addition to 
crystal violet for gram-positive bacteria in case of polymi-
crobial infection. Two outflow drains (28Fr Argyle™ tho-
racic catheter and 24Fr Trocar catheter, Covidien, Dublin, 
Fig. 1  Contrasted computed tomography. a Three-dimensional image 
of a 2-debranch TEVAR. b Endograft infection was not demonstrated 
on admission. c-1 Contrast enhancement around the endograft and 
fluid collection inside the remnant aneurysm. c-2 Fluid filled cavity 
(roughly the size of a chicken egg) between aortic arch and pulmo-
nary artery. d Postoperative 1  month. e Postoperative 2  years. No 
recurrence of endograft infection after thoracoscopic drainage and 
irrigation
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Fig. 2  Thoracoscopic drainage surgery. a Incision on the lateral side of aneurysm with scalpel. b Purulent fluid erupting from fenestration. c Set-
ting drainage tubes after drainage. Aneu aneurysm, ant anterior, post posterior
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Ireland) were placed on the diaphragm and at the apex of 
the left lung. Two inflow drains (10Fr  BLAKE® Silicone 
Drains, Ethicon, Newark, USA) (10Fr Nelaton catheter, 
Terumo, Tokyo, Japan) were placed lying on the fenestra-
tion (Fig. 2c).
The irrigation–drainage system was constructed postop-
eratively. Gentamycin, which is effective in gram-negative 
rod infection, was empirically diluted in 1000–2000 mL nor-
mal saline/day, and did not exceed the intravenous maxi-
mum dose (240 mg/day). By postoperative day (POD) 30, 
the abscesses had diminished upon CT imaging (Fig. 1d). 
His WBC count was normalized and CRP level stayed less 
than 0.03 mg/dL. E. coli was not cultured in the drainage 
fluid and blood, therefore we removed the inflow and outflow 
chest tubes on POD 32. After confirmation of no recurrent 
infection following drain removal, we decided to alter an 
intravenous cefozopran to oral amoxicillin (1.0 g/day) on 
POD 34. He recovered well and discharged on POD 92 via 
a rehabilitation hospital. In case of the next step as radical 
treatment such as total aortic arch replacement, we closely 
monitored his cholangitis and enhanced his ADL with reha-
bilitation. Oral amoxicillin was finished on POD 180 with 
a normal range of WBC count and CRP level. At current 
follow-up, he is now 28 months after drainage with no sign 
of recurrent infection including endograft infection and chol-
angitis (Fig. 1e).
Discussion
Endograft infection after TEVAR is a critical complication 
with high morbidity and mortality rates [1]. Contrasted CT, 
gallium scintigraphy and positron emission tomography 
would be useful to identify the endograft infection. Although 
complete excision of the infected endograft is optimal, 
open radical surgery is associated with a high periopera-
tive mortality (4–11%) and morbidity (35–67%) [1, 2, 4]. 
When conventional treatment requiring endograft excision 
is precluded, conservative treatment such as endograft pres-
ervation with antibiotic administration might be considered.
There has been much discussion on the management of 
endograft infection, and it is agreed that antibiotic admin-
istration must be given as a basic, first line of treatment. 
Fatima et al. reported that the most commonly identified 
organisms in the aortic wall were Staphylococcus aureus 
(63%) including methicillin-resistant Staphylococcus aureus, 
followed by Streptococcus and Pseudomonas in 24 infected 
endograft patients [4]. Fourteen patients (58%) among them 
suffered from polymicrobial infections, therefore broad-
spectrum antibiotics should be selected. They concluded 
that there was no consensus or data of the appropriate anti-
biotic dose, interval, and duration. In this respect, broad-
spectrum, life-long, and maximum-dose antibiotics should 
be considered. Additionally, we must also control primary 
infection as well as endograft infection to prevent its relapse.
Additional procedures supported by antibiotics, such as 
drainage, debridement, and irrigation, have recently dem-
onstrated enhanced outcomes [5–7]. Cernohorsky et al. 
reported favorable outcomes with 5 of 6 patients treated 
conservatively with debridement and irrigation. They sug-
gested that there could be room for conservative treatment 
when patients could not tolerate invasive treatment such as 
explant surgery [5]. Moulakalis et al. reported three cases 
of endograft infection that were successfully treated with 
endograft preservation by surgical debridement or percu-
taneous drainage [6]. However, these reports did not dis-
close the long-term outcomes and could not be considered 
as a conclusive treatment. Moulakalis et al. later performed 
a meta-analysis with a total of 55 patients who had previ-
ously undergone endograft preservation as reported in 41 
studies. The in-hospital mortality in endograft preservation 
was 42.0% up to 81.8% in the follow-up period, and signifi-
cantly worse than endograft excision. They mentioned that 
endograft excision remained the gold standard for endograft 
infection, whereas endograft preservation remained a tem-
porary or bridging solution.
However, it should be noted that the candidates for 
endograft preservation are mostly of an unstable condition 
with severe comorbidity. They may not be able to tolerate 
invasive treatment such as aortic surgery with thoracotomy. 
When we chose the endograft preservation with irrigation as 
conservative treatment, we have basically two approaches, 
including open thoracotomy or thoracoscopic surgery. Open 
thoracotomy might be optimal for its clear field of view and 
maneuverability in order to eliminate and decorticate the 
abscess completely. In addition, we can deal with uninten-
tional intraoperative bleeding immediately. On the other 
hand, thoracoscopic surgery is another approach and gen-
erally considered as a less invasive maneuver. Chan et al. 
reported that thoracoscopic surgery allows equally effective 
irrigation and decortication for empyema as thoracotomy, 
which gives less pain and greater patient acceptance [3]. 
This will be important especially for the patient with unsta-
ble condition and severe comorbidity. On the basis of this 
concept, our strategy of appropriate perioperative antibiotics 
administration, thoracoscopic drainage for the preservation 
of the infected endograft and continuous irrigation will be 
more effective and favorable combination as “maximally” 
less invasive therapy.
Our technique is limited to “non-endoleak” cases espe-
cially. With absolute confirmation of no endoleak, debride-
ment around the infected endograft and its subsequent 
preservation can be performed. In this respect, precise peri-
operative evaluation of endoleak is crucial, and we evalu-
ated it here with contrasted CT. Guo et al. performed the 
meta-analysis of the efficacy of contrasted CT for endoleak 
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detection, with 31 studies of 3853 EVAR patients. They 
mentioned that CT had a significantly higher proportion 
of endoleak detection than ultrasonography (US) and mag-
netic resonance imaging (MRI) [8]. Nevertheless, CT can-
not detect the endoleak perfectly; therefore, the combination 
of contrasted CT, US, and MRI will be effective to detect 
endoleak more precisely. If the bleeding with endoleak 
occurs under the limited thoracoscopic view field, it will 
be difficult to control. In our case, the fluid cavity was close 
to the proximal landing-zone of the endograft. Endograft 
infection can induce an endoleak and migration. We should 
be attentive to the distribution of infectious site and the 
landing-zone. Although intraoperative bleeding is a disaster, 
conversion from thoracoscopic surgery to open thoracotomy 
might be acceptable as second-line choice. Therefore, pre-
cise perioperative evaluation with CT and other methods, 
cooperation of thoracic surgeon familiar with thoracoscopic 
maneuver, and cardiopulmonary bypass back-up during sur-
gery are all essential.
Conclusion
In endovascular infection, surgical conversion as a final 
treatment may be postponed, but it may not be possible to 
avoid in the end. In unstable patients or those with severe 
comorbidities who cannot tolerate endograft excision and 
aortic reconstruction, thoracoscopic drainage with endograft 
preservation followed by continuous irrigation can be a tem-
porary or bridging solution in the growing endovascular era. 
A further study should be conducted to establish the efficacy 
of this strategy.
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